SCHEMBL30164142

SCHEMBL30164142

CCc1ccc(C#N)c(Cl)n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MBOAT4 Q96T53 1/20 0.45
ALDH1A1 P00352 1/20 0.43
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
KHK P50053 1/20 0.39
GAA P10253 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PGK1 P00558 1/20 0.39
GLA P06280 1/20 0.39
HTT P42858 1/20 0.39
KDM4E B2RXH2 1/20 0.38
MAPT P10636 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
PKM P14618 1/20 0.38
TSHR P16473 1/20 0.37
MAPK1 P28482 1/20 0.37
RPS6KA5 O75582 1/20 0.37
RPS6KA4 O75676 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2394294 1.00 MBOAT4 (0.45) MBOAT4ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL6184247 0.86 MBOAT4 (0.45) MBOAT4ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL7426416 0.83 MBOAT4 (0.42) MBOAT4ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL17316420 0.82 CCR1 (0.43) MBOAT4ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL30640933 0.82 CCR1 (0.43) MBOAT4ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL3526430 0.82 CCR1 (0.43) MBOAT4ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL9262850 0.81 TSHR (0.56) MBOAT4ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL7215435 0.79 L3MBTL1 (0.39) ALDH1A1GAAL3MBTL1GLAHTT
SCHEMBL10271764 0.79 MBOAT4 (0.39) MBOAT4ALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL7332467 0.78 PARP1 (0.37) ALDH1A1GAAL3MBTL1GLAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4377307-A1 COMPOUNDS FOR THE TREATMENT OF PAIN, IN PARTICULAR NEUROPATHIC PAIN, AND/OR OTHER DISEASES OR DISORDERS THAT ARE ASSOCIATED WITH AT2R AND/OR AT2R MEDIATED SIGNALING Confo Therapeutics N.V. (BE) 2024-06-05 EP disclosed
WO-2023006893-A1 COMPOUNDS FOR THE TREATMENT OF PAIN, IN PARTICULAR NEUROPATHIC PAIN, AND/OR OTHER DISEASES OR DISORDERS THAT ARE ASSOCIATED WITH AT2R AND/OR AT2R MEDIATED SIGNALING CONFO THERAPEUTICS N.V. (BE) 2023-02-02 WO disclosed